Please login to the form below

Not currently logged in
Email:
Password:

anti-COVID-19 drug

This page shows the latest anti-COVID-19 drug news and features for those working in and with pharma, biotech and healthcare.

Gilead sales rise by 13%, buoyed by anti-COVID-19 drug Veklury

Gilead sales rise by 13%, buoyed by anti-COVID-19 drug Veklury

Gilead has reported third-quarter sales of $7.4bn, an increase of 13% compared to the same period last year, due to increased demand for its COVID-19 antiviral Veklury (remdesivir). ... Veklury is making a significant impact as the COVID-19 pandemic

Latest news

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....